Unisys Publishes AI Evaluation Framework for Drug Repurposing

Sep 3, 2026
Unisys has published peer reviewed research proposing a framework for evaluating AI systems used in drug repurposing. The framework assesses mechanistic coherence, uncertainty, robustness, and provenance.
Unisys Publishes AI Evaluation Framework for Drug Repurposing
Image: By Pereirrm1 - Own work

Unisys announced in a press release that its peer reviewed research on explainable AI for drug repurposing has been published in Frontiers in Pharmacology. The paper examines a neurosymbolic approach that combines AI methods with human knowledge and reasoning to make recommendations more transparent.

The research introduces the MURP framework, which evaluates mechanistic coherence, uncertainty, robustness, and provenance. It is designed to assess AI systems beyond predictive accuracy when they are used in healthcare and other regulated settings.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.